Document Detail

Diuretic bioactivity optimization of furosemide in rats.
MedLine Citation:
PMID:  21571067     Owner:  NLM     Status:  Publisher    
Furosemide is a loop diuretic widely used by patients with congestive heart failure (CHF) to rid excess body water, reducing blood pressure, and mobilizing edemas. However, due to the narrow window of furosemide absorption, occurring only in the proximal gastrointestinal tract, only immediate release oral formulations are clinically available. Comparisons of bolus and continuous administration of furosemide in intravenous settings demonstrate that continuous administration at lower concentrations produced greater diuretic efficiency and reduced subsequent hospitalization rates in patients experiencing severe CHF. We report a systematic investigation of the diuretic bioactivity profiles of phase inversion micronized furosemide and furosemide co-precipitated with Eudragit L100, as well as their blends with stock furosemide, targeted at reducing the rapid spike in diuresis associated with immediate release formulations while maintaining cumulative urine output. Of the formulations tested, an equal parts blend of micronized furosemide and stock furosemide demonstrated optimal diuretic bioactivity profiles in a rat model.
Bryan Laulicht; Anubhav Tripathi; Edith Mathiowitz
Related Documents :
21773677 - Electrocardiographic findings of palonosetron in cancer patients.
22011557 - Ivabradine versus metoprolol for heart rate reduction before coronary computed tomograp...
22102787 - Effects of smoking cessation on central blood pressure and arterial stiffness.
21970937 - Cardiac structure and function in relation to central blood pressure components in chin...
1987107 - Recovery of retinal pigment epithelial function after ischemia in the rabbit.
12412837 - Cardiovascular system effects of marijuana.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2011-5-5
Journal Detail:
Title:  European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V     Volume:  -     ISSN:  1873-3441     ISO Abbreviation:  -     Publication Date:  2011 May 
Date Detail:
Created Date:  2011-5-16     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9109778     Medline TA:  Eur J Pharm Biopharm     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
Copyright © 2011 Elsevier B.V. All rights reserved.
Department of Molecular Pharmacology, Physiology, and Biotechnology, Brown University, Providence, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Induction of Th1 polarized immune responses by thiolated Eudragit-coated F4 and F18 fimbriae of ente...
Next Document:  Functional analysis of a pancreatic secretory trypsin inhibitor-like protein in insects: Silencing e...